insights
November 17, 20266 min readDRMED Medical Affairs

Minimal Erythema Dose and Phototesting: Why Skin Assessment Comes First

Before any energy-based device touches the skin, there is a question that has to be answered first: how will this particular patient's skin respond to light or thermal energy at all? Minimal erythema dose (MED) and broader phototesting are the tools clinicians have used for decades, originally in phototherapy and photobiology, to answer that question in a measured, individualized way rather than guessing from skin type alone.

What Minimal Erythema Dose Actually Measures

MED is defined as the lowest dose of light energy, usually ultraviolet in the classical dermatology sense, that produces visible, clearly demarcated redness on a given person's skin within a set observation window. It is a threshold, not a treatment dose. The concept matters because individual variation in how skin reacts to light energy is substantial even within the same Fitzpatrick category, which is a broad classification based on self-reported tanning and burning history rather than a direct physiological measurement. Two patients with the same Fitzpatrick score can still have meaningfully different erythema thresholds, which is exactly the gap that phototesting is designed to close.

Phototesting Beyond Classical UV Dermatology

In modern aesthetic and dermatology practice, the underlying logic of phototesting has extended to energy-based devices more broadly, including lasers and intense pulsed light systems. Clinicians may perform a small test spot or patch exposure, observe the skin's response over a defined interval, and use that observed reaction, rather than skin type alone, to inform how a device's parameters should be approached for that individual. This is a professional assessment step, not a step the device or the patient skips by relying on a chart. The evidence base for structured test-spot protocols varies by device category and indication, and clinicians should rely on the specific guidance published for the device class they are using.

Why Skin Type Classification Alone Is an Incomplete Proxy

Fitzpatrick typing remains a useful starting framework because it is fast, well understood, and correlates broadly with melanin content and photosensitivity. But it was originally developed to describe sunburn and tanning response, not to serve as a precision input for laser or light-based device settings. Factors such as recent sun exposure, use of photosensitizing medications, ethnic and regional variation in melanin distribution, and localized skin conditions can all shift an individual's actual threshold away from what their Fitzpatrick category alone would predict. This is why many professional guidelines frame skin typing as a first-pass screening tool and phototesting or careful observed test exposures as the more individualized follow-up where device risk profiles warrant it.

How This Connects to Device Selection and Procurement

For distributors and institutional buyers, the relevance of MED and phototesting concepts is less about the clinical procedure itself and more about understanding why manufacturers publish parameter ranges rather than fixed settings for a given skin type. A device cleared across a range of skin types will typically document that clinicians are expected to titrate or test before full treatment, rather than apply one universal setting. Procurement teams reviewing device documentation can reasonably expect to see:

  • Guidance referencing skin type classification as a starting point, not a final answer.
  • Instructions that describe test-exposure or conservative-start approaches where relevant to the device category.
  • Clear statements that final parameter selection is a clinical decision made at the point of care.

The Takeaway

Minimal erythema dose and phototesting represent a long-standing principle in photobiology: that individual skin response to light and thermal energy varies enough that classification systems like Fitzpatrick typing function best as a starting point for clinical judgment, not a substitute for it. For device buyers and distributors, recognizing this helps make sense of why responsible manufacturer documentation emphasizes clinician-led assessment and conservative, individualized parameter selection over one-size-fits-all settings.

This article is educational and does not constitute medical advice. Product selection, dosing and administration must always be performed by a qualified healthcare professional.